Sleep therapy may tame blood sugar in type 1 diabetes

NCT ID NCT07091318

Recruiting now Symptom relief Sponsor: University of Illinois at Chicago Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether cognitive behavioral therapy for insomnia (CBTi) can improve sleep, blood sugar levels, and quality of life in adults with type 1 diabetes. Fifteen participants will either receive 8 virtual CBTi sessions or health education emails and calls over 12 weeks. Researchers will measure sleep quality, glucose control, and how acceptable the therapy is.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cognitive behavioral therapy for insomnia (CBTi) delivered virtually
What this could lead to: If it works, this could point toward a non-drug way to improve sleep and blood sugar control in people with type 1 diabetes.
What could go wrong: This is a very small early-phase trial with only 15 participants, so results may not apply to everyone. It also relies on self-reported sleep and may not show clear benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus insomnia type 1 diabetes mellitus type 1 diabetes mellitus 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 1 INSOMNIA

Contacts and locations

Locations

University of Illinois Chicago
RECRUITING

Chicago, Illinois, 60612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.